20. Comparing Lepodisiran to Statins

While statins are proven to lower LDL cholesterol and reduce heart attack risk, they have no effect on Lp(a) levels. Lepodisiran is unique because it directly targets Lp(a), addressing a treatment gap for those with genetically high Lp(a) who don’t benefit from statins alone.
For statin details, see the CDC’s resource on statin use.